Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.
- DOI
- 10.1016/s2352-3026(22)00073-4
- Published
- 2022 May
- Container
- The Lancet. Haematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-3026-22-00073-4,
title = {Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.},
author = {Stemler J and de Jonge N and Skoetz N and Sinkó J and Brüggemann RJ and Busca A and Ben-Ami R and Ráčil Z and Piechotta V and Lewis R and Cornely OA},
year = {2022},
journal = {The Lancet. Haematology},
doi = {10.1016/s2352-3026(22)00073-4},
url = {https://doi.org/10.1016/s2352-3026(22)00073-4}
}RIS
TY - JOUR TI - Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association. AU - Stemler J AU - de Jonge N AU - Skoetz N AU - Sinkó J AU - Brüggemann RJ AU - Busca A AU - Ben-Ami R AU - Ráčil Z AU - Piechotta V AU - Lewis R AU - Cornely OA PY - 2022 JO - The Lancet. Haematology DO - 10.1016/s2352-3026(22)00073-4 UR - https://doi.org/10.1016/s2352-3026(22)00073-4 ER -
APA
J, S., N, D. J., N, S., J, S., RJ, B., A, B., R, B., Z, R., V, P., R, L., & OA, C. (2022). Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.. The Lancet. Haematology. https://doi.org/10.1016/s2352-3026(22)00073-4
Source records
- pubmed · retrieved 2026-09-26T18:54:39.594Z